RenovoRx’s Board Member Dr. Laurence (Larry) J. Marton, MD is a leading expert with extensive experience in the fields of drug development, with a focus on treating human diseases related to cell growth including cancer. Today, Dr. Marton has released a very informative interview to Mendelspod, which produces engaging, thoughtful thirty minute shows twice a week on highly relevant topics to those working around the life sciences. Dr. Marton’s core message is that we must improve the quality of new clinical tests which have been translated from research. It is the key to demonstrating clinical relevance, he says. There are issues with sampling, with analytics, and with compliance. What can those in the industry do to better the quality assurance? And how can the industry better engage the medical community? Our Board Member shares his insights at Mendelspod.com/Larry.
RenovoRx Advances TAMP™ into Borderline Resectable Pancreatic Cancer with First Patient Enrolled in Investigator-Initiated PRISM-TAMP Trial
October 7, 2026
RenovoRx today announced the publication of a peer-reviewed case series in Case Reports in Oncology from researchers at Hackensack Meridian Health’s Jersey Shore University Medical Center.